Reuters logo
BRIEF-Sanofi India says news on FDA approval for eczema drug not related to co
March 29, 2017 / 9:39 AM / 6 months ago

BRIEF-Sanofi India says news on FDA approval for eczema drug not related to co

March 29 (Reuters) - Sanofi India Ltd:

* Clarifies on news item “FDA approves Regeneron, Sanofi $37,000 per year eczema drug”

* News is not relating to ops of Sanofi India Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below